Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc +1 more source
Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir [PDF]
openaire +1 more source
Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]
O'Rourke J +10 more
europepmc +1 more source
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV. [PDF]
Zheng Y +16 more
europepmc +1 more source
Dual Long-Acting Cabotegravir/Rilpivirine Plus Lenacapavir in Integrase Strand Transfer Inhibitor Resistance: A Case Report and Review of the Literature. [PDF]
Seo L, Reilly-Evans B, Garland J.
europepmc +1 more source
Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study. [PDF]
Mounzer K +10 more
europepmc +1 more source
Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium. [PDF]
Lopez Delhoulle V +5 more
europepmc +1 more source
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib. [PDF]
Overbeek JK +6 more
europepmc +1 more source
Care of HIV Patients in Long-Term Care Facilities: A Growing Concern and a Call to Action. [PDF]
Liu M, King WD, Butler D, Liu MH.
europepmc +1 more source
Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report. [PDF]
Sunagawa SW +10 more
europepmc +1 more source

